According to Aurobindo Pharma 's latest financial reports the company's total debt is $0.80 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-03-31 | $0.64 B | 48.9% |
2022-03-31 | $0.43 B | -40.52% |
2021-03-31 | $0.72 B | -13.01% |
2020-03-31 | $0.83 B | -16.71% |
2019-03-31 | $1.00 B | 36.96% |
2018-03-31 | $0.73 B | 41.1% |
2017-03-31 | $0.51 B | -31.64% |
2016-03-31 | $0.75 B | 8.01% |
2015-03-31 | $0.70 B | 11.64% |
2014-03-31 | $0.62 B | -0.48% |
2013-03-31 | $0.63 B | 3.99% |
2012-03-31 | $0.60 B | 12.46% |
2011-03-31 | $0.54 B | 12.53% |
2010-03-31 | $0.48 B | 4.17% |
2009-03-31 | $0.46 B | -4.02% |
2008-03-31 | $0.48 B | -0.38% |
2007-03-31 | $0.48 B | 55.94% |
2006-03-31 | $0.30 B | 30.59% |
2005-03-31 | $0.23 B | 24.83% |
2004-03-31 | $0.18 B |